levofloxacin has been researched along with glycosides in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (glycosides) | Trials (glycosides) | Recent Studies (post-2010) (glycosides) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 20,179 | 169 | 6,844 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, J; Hao, XY; Li, ZS; Wang, GC; Zuo, GY | 1 |
| Hsueh, PR; Ko, WC; Liao, CH; Lu, JJ | 1 |
2 other study(ies) available for levofloxacin and glycosides
| Article | Year |
|---|---|
Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Drug Synergism; Flavonols; Glycosides; Humans; Hypericum; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin; Quercetin; Sputum | 2011 |
Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan.
Topics: Anti-Infective Agents; Aza Compounds; Bacterial Proteins; Clostridioides difficile; Fluoroquinolones; Gemifloxacin; Glycosides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Rifamycins; Rifaximin; Taiwan; Vancomycin | 2012 |